174 related articles for article (PubMed ID: 26914979)
1. Outcomes for paediatric Burkitt lymphoma treated with anthracycline-based therapy in Malawi.
Stanley CC; Westmoreland KD; Heimlich BJ; El-Mallawany NK; Wasswa P; Mtete I; Butia M; Itimu S; Chasela M; Mtunda M; Chikasema M; Makwakwa V; Kaimila B; Kasonkanji E; Chimzimu F; Kampani C; Dhungel BM; Krysiak R; Montgomery ND; Fedoriw Y; Rosenberg NE; Liomba NG; Gopal S
Br J Haematol; 2016 Jun; 173(5):705-12. PubMed ID: 26914979
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of Burkitt lymphoma treatment in adolescents and adults in Malawi.
Painschab MS; Westmoreland KD; Kasonkanji E; Zuze T; Kaimila B; Waswa P; El-Mallawany NK; Tomoka T; Mulenga M; Montgomery ND; Fedoriw Y; Gopal S
Blood Adv; 2019 Feb; 3(4):612-620. PubMed ID: 30796065
[TBL] [Abstract][Full Text] [Related]
3. CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi.
Gopal S; Fedoriw Y; Kaimila B; Montgomery ND; Kasonkanji E; Moses A; Nyasosela R; Mzumara S; Varela C; Chikasema M; Makwakwa V; Itimu S; Tomoka T; Kamiza S; Dhungel BM; Chimzimu F; Kampani C; Krysiak R; Richards KL; Shea TC; Liomba NG
PLoS One; 2016; 11(3):e0150445. PubMed ID: 26934054
[TBL] [Abstract][Full Text] [Related]
4. Outcome is unchanged by adding vincristine upfront to the Malawi 28-day protocol for endemic Burkitt lymphoma.
Depani S; Banda K; Bailey S; Israels T; Chagaluka G; Molyneux E
Pediatr Blood Cancer; 2015 Nov; 62(11):1929-34. PubMed ID: 26052841
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of chemotherapy in Chinese patients with AIDS-related Burkitt lymphoma and diffuse large B-cell lymphoma: An observational study.
Xiao J; Du S; Dai G; Gao G; Yang D; Zhao H
Sci Rep; 2017 May; 7(1):1905. PubMed ID: 28507339
[TBL] [Abstract][Full Text] [Related]
6. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
[TBL] [Abstract][Full Text] [Related]
7. The 2000 Burkitt lymphoma trial in Malawi.
Hesseling P; Broadhead R; Mansvelt E; Louw M; Wessels G; Borgstein E; Schneider J; Molyneux E
Pediatr Blood Cancer; 2005 Mar; 44(3):245-50. PubMed ID: 15547922
[TBL] [Abstract][Full Text] [Related]
8. Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi.
Westmoreland KD; Montgomery ND; Stanley CC; El-Mallawany NK; Wasswa P; van der Gronde T; Mtete I; Butia M; Itimu S; Chasela M; Mtunda M; Kampani C; Liomba NG; Tomoka T; Dhungel BM; Sanders MK; Krysiak R; Kazembe P; Dittmer DP; Fedoriw Y; Gopal S
Int J Cancer; 2017 Jun; 140(11):2509-2516. PubMed ID: 28268254
[TBL] [Abstract][Full Text] [Related]
9. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU
Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525
[TBL] [Abstract][Full Text] [Related]
10. The use of anthracyclines in the treatment of endemic Burkitt lymphoma.
Molyneux E; Schwalbe E; Chagaluka G; Banda K; Israels T; Depani S; Mittermayer-Vassallo K; Windebank K; Mvula J; Njiram'madzi J; O'Brien S; Carey P; Bailey S
Br J Haematol; 2017 Jun; 177(6):984-990. PubMed ID: 27891583
[TBL] [Abstract][Full Text] [Related]
11. Advanced Burkitt Lymphoma in Sub-Saharan Africa Pediatric Units: Results of the Third Prospective Multicenter Study of the Groupe Franco-Africain d'Oncologie Pédiatrique.
Bouda GC; Traoré F; Couitchere L; Raquin MA; Guedenon KM; Pondy A; Moreira C; Rakotomahefa M; Harif M; Patte C
J Glob Oncol; 2019 Nov; 5():1-9. PubMed ID: 31794283
[TBL] [Abstract][Full Text] [Related]
12. Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa.
Ozuah NW; Lubega J; Allen CE; El-Mallawany NK
Blood Adv; 2020 Aug; 4(16):4007-4019. PubMed ID: 32841337
[TBL] [Abstract][Full Text] [Related]
13. Influence of amifostine on toxicity of CHOP in elderly patients with aggressive non-Hodgkin's lymphoma--a phase II study.
Späth-Schwalbe E; Lange C; Genvresse I; Krüger L; Eucker J; Schweigert M; Sezer O; Budach V; Possinger K
Anticancer Drugs; 2002 Apr; 13(4):395-403. PubMed ID: 11984085
[TBL] [Abstract][Full Text] [Related]
14. Survival of children with endemic Burkitt lymphoma in a prospective clinical care project in Uganda.
McGoldrick SM; Mutyaba I; Adams SV; Larsen A; Krantz EM; Namirembe C; Mooka P; Nabakooza S; Ndagire M; Mubiru K; Nabwana M; Nankinga R; Gerdts S; Gordon-Maclean C; Geriga F; Omoding A; Sessle E; Kambugu J; Uldrick TS; Orem J; Casper C
Pediatr Blood Cancer; 2019 Sep; 66(9):e27813. PubMed ID: 31157502
[TBL] [Abstract][Full Text] [Related]
15. Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol.
Diviné M; Casassus P; Koscielny S; Bosq J; Sebban C; Le Maignan C; Stamattoulas A; Dupriez B; Raphaël M; Pico JL; Ribrag V; ;
Ann Oncol; 2005 Dec; 16(12):1928-35. PubMed ID: 16284057
[TBL] [Abstract][Full Text] [Related]
16. AIDS-associated Burkitt or Burkitt-like lymphoma: short intensive polychemotherapy is feasible and effective.
Hoffmann C; Wolf E; Wyen C; Fätkenheuer G; Van Lunzen J; Stellbrink HJ; Stoehr A; Plettenberg A; Jaeger H; Noppeney R; Hentrich M; Goekbuget N; Hoelzer D; Horst HA
Leuk Lymphoma; 2006 Sep; 47(9):1872-80. PubMed ID: 17065000
[TBL] [Abstract][Full Text] [Related]
17. Malawi pilot study of Burkitt lymphoma treatment.
Hesseling PB; Broadhead R; Molyneux E; Borgstein E; Schneider JW; Louw M; Mansvelt EP; Wessels G
Med Pediatr Oncol; 2003 Dec; 41(6):532-40. PubMed ID: 14595710
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.
Kojima Y; Hagiwara S; Uehira T; Ajisawa A; Kitanaka A; Tanuma J; Okada S; Nagai H
Jpn J Clin Oncol; 2014 Apr; 44(4):318-23. PubMed ID: 24558129
[TBL] [Abstract][Full Text] [Related]
19. An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study.
Mead GM; Sydes MR; Walewski J; Grigg A; Hatton CS; Pescosta N; Guarnaccia C; Lewis MS; McKendrick J; Stenning SP; Wright D;
Ann Oncol; 2002 Aug; 13(8):1264-74. PubMed ID: 12181251
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment with modified CHOP-rituximab in pediatric AIDS-related advanced stage Burkitt lymphoma.
Crosswell HE; Bergsagel DJ; Yost R; Lew G
Pediatr Blood Cancer; 2008 Apr; 50(4):883-5. PubMed ID: 17278123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
